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Abstract
The food enzyme is a glucose oxidase (beta-D-glucose:oxygen 1-oxidoreductase; EC 1.1.3.4) produced
with a genetically modified strain of Aspergillus oryzae strain NZYM-KP by Novozymes A/S. The genetic
modifications do not give rise to safety concerns. The food enzyme does not contain the production
organism or DNA; therefore, there is no safety concern for the environment. The glucose oxidase is
intended to be used in baking processes. Based on the maximum use levels recommended and individual
consumption data from the EFSA Comprehensive European Food Consumption Database, dietary
exposure to the food enzyme–total organic solids (TOS) was estimated to be up to 0.156 mg TOS/kg
body weight (bw) per day in European populations. The food enzyme did not induce gene mutations in
bacteria or chromosome aberrations in human lymphocytes. The subchronic toxicity was assessed by
means of a repeated dose 90-day oral toxicity study in rodents. A no-observed-adverse-effect level was
derived (341 mg TOS/kg bw per day), which compared with the estimated dietary exposure results in a
sufficiently high margin of exposure. The allergenicity was evaluated by comparing the amino acid
sequence to those of known allergens and one match with a fungal contact allergen was found. The
Panel considered that, under the intended condition of use, the risk of allergic sensitisation and elicitation
reactions by dietary exposure cannot be excluded, but the likelihood is considered low. Based on the
microbial source, the genetic modifications, the manufacturing process, the compositional and
biochemical data, the estimated dietary exposure and the findings in the toxicological studies, the
Panel concluded that this food enzyme does not give rise to safety concerns under the intended
conditions of use.
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1. Introduction
Article 3 of the Regulation (EC) No 1332/20081 provides definitions for ‘food enzyme’ and ‘food
enzyme preparation’.
‘Food enzyme’ means a product obtained from plants, animals or micro-organisms or products
thereof including a product obtained by a fermentation process using micro-organisms: (i) containing
one or more enzymes capable of catalysing a specific biochemical reaction; and (ii) added to food for a
technological purpose at any stage of the manufacturing, processing, preparation, treatment,
packaging, transport or storage of foods.
‘Food enzyme preparation’ means a formulation consisting of one or more food enzymes in which
substances such as food additives and/or other food ingredients are incorporated to facilitate their
storage, sale, standardisation, dilution or dissolution.
Before January 2009, food enzymes other than those used as food additives were not regulated or
were regulated as processing aids under the legislation of the Member States. On 20 January 2009,
Regulation (EC) No 1332/2008 on food enzymes came into force. This Regulation applies to enzymes
that are added to food to perform a technological function in the manufacture, processing,
preparation, treatment, packaging, transport or storage of such food, including enzymes used as
processing aids. Regulation (EC) No 1331/20082 established European Union (EU) procedures for the
safety assessment and the authorisation procedure of food additives, food enzymes and food
flavourings. The use of a food enzyme shall be authorised only if it is demonstrated that:
i) it does not pose a safety concern to the health of the consumer at the level of use proposed,
ii) there is a reasonable technological need, and
iii) its use does not mislead the consumer.
All food enzymes currently on the EU market and intended to remain on that market as well as all
new food enzymes shall be subjected to a safety evaluation by the European Food Safety Authority
(EFSA) and approval via an EU Community list.
The ‘Guidance on submission of a dossier on food enzymes for safety evaluation’ (EFSA CEF Panel,
2009) lays down the administrative, technical and toxicological data required.
1.1. Background and Terms of Reference as provided by the requestor
1.1.1. Background as provided by the European Commission
Only food enzymes included in the Union list may be placed on the market as such and used in
foods, in accordance with the specifications and conditions of use provided for in Article 7 (2) of
Regulation (EC) No 1332/2008 on food enzymes.
Three applications have been introduced by the company Novozymes A/S for the authorisation of
the food enzymes Alpha-amylase from a genetically modified strain of Bacillus licheniformis (strain
NZYM-BC), Amyloglucosidase from a genetically modified strain of Aspergillus niger (strain NZYM-BR)
and Glucose oxidase from a genetically modified strain of Aspergillus oryzae (strain NZYM-KP).
Following the requirements of Article 12.1 of Commission Regulation (EU) No 234/20113
implementing Regulation (EC) No 1331/2008, the Commission has verified that the application falls
within the scope of the food enzyme Regulation and contains all the elements required under Chapter
II of that Regulation.
1.1.2. Terms of Reference
The European Commission requests the European Food Safety Authority to carry out the safety
assessments on the food enzymes Alpha-amylase from a genetically modified strain of Bacillus
licheniformis (strain NZYM-BC), Amyloglucosidase from a genetically modified strain of Aspergillus niger
1 Regulation (EC) No 1332/2008 of the European Parliament and of the Council of 16 December 2008 on Food Enzymes and
Amending Council Directive 83/417/EEC, Council Regulation (EC) No 1493/1999, Directive 2000/13/EC, Council Directive 2001/
112/EC and Regulation (EC) No 258/97. OJ L 354, 31.12.2008, p. 7–15.
2 Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a common
authorisation procedure for food additives, food enzymes and food flavourings. OJ L 354, 31.12.2008, p. 1–6.
3 Commission Regulation (EU) No 234/2011 of 10 March 2011 implementing Regulation (EC) No 1331/2008 of the European
Parliament and of the Council establishing a common authorisation procedure for food additives, food enzymes and food
flavourings. OJ L 64, 11.3.2011, p. 15–24.
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(strain NZYM-BR) and Glucose oxidase from a genetically modified strain of Aspergillus oryzae (strain
NZYM-KP) in accordance with Article 17.3 of Regulation (EC) No 1332/2008 on food enzymes.
1.2. Interpretation of the Terms of Reference
The present scientific opinion addresses the European Commission’s request to carry out the safety
assessment of the food enzyme glucose oxidase from a genetically modified strain of Aspergillus
oryzae (strain NZYM-KP).
1.3. Information on existing authorisations and evaluations
The applicant reports that Danish and French authorities have evaluated and authorised the use of
glucose oxidase from a genetically modified strain of A. oryzae (strain NZYM-KP) in baking processes.
The Danish authority also sets out the conditions of use, including the dosages for specific foods,
which is up to 500 GODU/kg flour.
2. Data and methodologies
2.1. Data
The applicant has submitted a dossier supporting the application for authorisation of the food
enzyme glucose oxidase from a genetically modified strain of A. oryzae (strain NZYM-KP). The food
enzyme is intended to be used in baking processes.
2.2. Methodologies
The assessment was conducted in line with the principles described in the EFSA ‘Guidance on
transparency in the scientific aspects of risk assessment’ (EFSA, 2009) and following the relevant
existing guidances from the EFSA Scientific Committee.
The current ‘Guidance on submission of a dossier on food enzymes for safety evaluation’ (EFSA CEF
Panel, 2009) has been followed for the evaluation of the application with the exception of the
exposure assessment, which was carried out in accordance to the methodology described in the CEF
Panel statement on the exposure assessment of food enzymes (EFSA CEF Panel, 2016).
3. Assessment
3.1. Technical data
3.1.1. Identity of the food enzyme
IUBMB nomenclature: Glucose oxidase
Systematic name: Beta-D-glucose:oxygen 1-oxidoreductase
Synonyms: Beta-D-glucose oxidase; beta-D-glucose:quinone oxidoreductase




The glucose oxidase produced with the genetically modified A. oryzae strain NZYM-SP is a single
polypeptide chain of 581 amino acids. The molecular mass derived from the amino acid sequence was
calculated to be 63 kDa. The protein homogeneity status of the food enzyme was investigated by
sodium dodecyl sulfate-poly acrylamide gel electrophoresis (SDS-PAGE) analysis. The apparent
molecular mass based on this technique is about 82–88 kDa identified with one band. The difference is
expected to be due to glycosylation.
The food enzyme has been tested for other enzymatic activities. The protease, alpha-amylase,
lipase and glucoamylase activities were below the detection limits of the employed methods. The food
enzyme shows catalase activity, according to the applicant, the average activity of catalase determined
in the three commercial batches is substantially lower than the activities in commercial catalase food
enzymes.
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Data on the chemical parameters of the food enzyme have been provided for three commercial
batches and one batch used for the toxicological tests (Table 1). The average total organic solids
(TOS) content of the three commercial food enzyme batches was 9.8% (w/w); the values ranged from
8.9% to 11.4% (Table 1). The TOS content is a calculated value derived as 100% minus % water
minus % ash.
The enzyme activity/TOS ratio of the three commercial food enzyme batches ranged from 50.53 to
93.71 GODU/mg TOS (Table 1). The average value of 72 GODU/mg TOS was used for subsequent
calculations.
The food enzyme complies with the specification for lead (not more than 5 mg/kg) as laid down in
the general specifications and considerations for enzymes used in food processing (FAO/WHO, 2006).
In addition, the levels of arsenic, cadmium and mercury in the four batches were below the limits of
detection of the employed methodologies.4
The presence of secondary metabolites (beta-nitropropionic acid and cyclopiazonic acid) was
examined in the four food enzyme batches and they were below the limits of detection of the applied
analytical methods.
The food enzyme complies with the microbiological criteria as laid down in the general
specifications and considerations for enzymes used in food processing (FAO/WHO, 2006), which
stipulate that Escherichia coli and Salmonella species are absent in 25 g of sample and total coliforms
should not exceed 30 colony forming units (CFU) per gram.
The applicant has provided information on the identities of the antifoam agents used. Taking into
account the nature and properties of the antifoam agents, the manufacturing process and the quality
assurance system implemented by the applicant, the Panel considers their use as of no safety concern.
The Panel considered the compositional data provided for the food enzyme as sufficient.
3.1.3. Properties of the food enzyme
The glucose oxidase catalyses the oxidation of b-D-glucose to D-glucono-d-lactone and hydrogen
peroxide using molecular oxygen as acceptor of electrons.
The glucose oxidase activity is expressed in Glucose Oxidase Units/g (GODU/g) (reaction
conditions: pH 5.6, temperature 30°C, reaction time 30 min). One unit of GODU is defined as the
amount of enzyme which oxidises 1 lmol of b-D-glucose in 1 min. In the assay, the reaction catalysed
by the glucose oxidase is coupled with a second one catalysed by a peroxidase. This peroxidase uses
the formed hydrogen peroxide to oxidise 2,2-azino-di-(3-ethylbenzthiazoline)-6-sulfonate (ABTS). The
oxidation of the latter substrate is measured spectrophotometrically at 405 nm and is proportional to
the amount of glucose oxidised during the first reaction.
Data showed that catalase activity was not sufficient to interfere with the determination of food
enzyme activity.
The glucose oxidase has been characterised regarding its activity depending on temperature and
pH. The glucose oxidase is active at temperatures up to 70°C (with an optimum of 50–60°C at pH 6)
and within a pH range of 2–10 (with an optimum of pH 3–5.5 at 30°C). The thermostability of the food
enzyme was tested over a range of 25–90°C after a pre-incubation at the different temperatures for
Table 1: Compositional data provided for the food enzyme
Parameter Unit
Batch
1 2 3 4(a)
Glucose oxidase activity GODU/g batch(b) 8,340 6,450 5,760 4,790
Protein % 7.44 6.50 7.13 4.88
Ash % 2.5 2.4 2.3 2.4
Water % 88.6 88.6 86.3 86.9
Total organic solids (TOS)(c) % 8.9 9.0 11.4 10.7
Glucose oxidase activity/mg TOS GODU/mg TOS 93.7 71.7 50.5 44.7
(a): Batch used for the toxicological tests.
(b): GODU: Glucose Oxidase Units (see Section 3.1.3).
(c): TOS calculated as 100% – % water – % ash.
4 Limit of detection: Pb: 0.5 mg/kg; As: 0.1 mg/kg; Cd: 0.05 mg/k; Hg: 0.03 mg/kg.
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30 min at pH 6. The activity itself was measured at pH 6 and 30°C. The food enzyme retained its
activity at temperatures up to 60°C. At higher temperatures, the food enzyme rapidly loses its activity;
above 80°C, no activity remains after 30 min.
3.1.4. Information on the source material
3.1.4.1. Information related to the genetically modified microorganism
The glucose oxidase is produced with the genetically modified production strain A. oryzae NZYM-KP,
which is deposited in the
with the deposit number .
3.1.4.2. Characteristics of the parental and recipient microorganisms
The A. oryzae recipient strain, , has been developed from the parental strain A. oryzae
. The taxonomic classification of both the parental and the recipient strain has been confirmed
by
. The recipient strain has a long history of use in the production of food enzymes.






3.1.4.3. Characteristics of introduced sequences
The gene encoding the glucose oxidase,
3.1.4.4. Description of the genetic modification process
A clone
showing increased expression of glucose oxidase was selected as the production strain (NZYM-KP).
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3.1.4.5. Safety aspects of the production strain
The production strain NZYM-KP differs from the recipient strain
The genetic modifications do not raise safety concerns.
3.1.5. Manufacturing process
The food enzyme is manufactured according to Food Hygiene Regulation (EC) No 852/20045, with
food safety procedures based on Hazard Analysis and Critical Control Points (HACCP), and in
accordance with Good Manufacturing Practice (GMP).
The food enzyme is produced by a pure culture in a contained, , fermentation
system with conventional process controls in place.
After completion of the fermentation, the solid biomass is removed from the fermentation broth by
filtration. The filtrate containing the enzyme is then further purified and concentrated by .
After stabilisation with , the food enzyme preparation is commercialised as a liquid
and solid product.
The production strain could not be detected in
No DNA from the production strain was detected in
The Panel considered the information provided on the raw materials and the manufacturing process
as to be sufficient.
3.1.6. Safety for the environment
The production strain and its DNA were not detected in the final product. Therefore, the
Panel concluded that there is no safety concern for the environment.
3.1.7. Case of need and intended conditions of use
The original uses proposed by the applicant were baking and cereal-based processes. In the course
of the evaluation process, the applicant informed EFSA about withdrawal of the intended use in cereal
based processes.
The resulting intended use is in baking processes at recommended use level up to 1,000 GODU/kg
flour, corresponding to 13.9 mg TOS/kg flour.
In baking processes, glucose oxidase is used to increase the strength of the dough and facilitate its
handling. The food enzyme is added during mixing of the raw materials.
5 Regulation (EC) No 852/2004 of the European Parliament and of the Council of 29 April 2004 on the hygiene of food additives.
OJ L 226, 25.6.2004, p. 3–21.
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3.1.8. Reaction and fate in food
The glucose oxidase catalyses the oxidation of b-D-glucose to D-glucono-d-lactone and hydrogen
peroxide using molecular oxygen as acceptor of electrons.
The D-glucono-d-lactone is permitted as a carrier in food enzymes.6
Hydrogen peroxide is considered to be the active agent responsible for the intended function of
glucose oxidase in dough preparation. Hydrogen peroxide reinforces the gluten network via oxidation
of cysteine residues and the resulting formation of disulfide bonds (Bonet et al., 2006). In addition,
hydrogen peroxide has been shown to induce the formation of dityrosine cross links through oxidative
coupling of tyrosine residues in gluten proteins (Tilley et al., 2001; Takasaki et al., 2005). These
reactions naturally occur during the preparation of dough; the use of the glucose oxidase is intended
to promote these reactions, and thereby improve and/or standardise the rheological properties of the
dough. Although the food enzyme contains catalase, which degrades hydrogen peroxide in the dough,
the applicant demonstrated that the activity present was insufficient to affect the levels of hydrogen
peroxide produced by the action of the glucose oxidase.
The glucose oxidase is specific in its action under the intended conditions of use and is not known
to catalyse other reactions than this oxidation of glucose leading to the formation of hydrogen
peroxide and D-glucono-1,5-lactone. Concerning the reactions of hydrogen peroxide in the dough,
there is no expectation of oxidation products other than those normally formed during the dough-
making and baking processes.
According to the data provided on the thermostability, it is anticipated that the glucose oxidase is
inactivated during baking processes under the conditions of use.
3.2. Dietary exposure
Dietary exposure estimates were calculated using the methodology described in the CEF
Panel statement on the exposure assessment of food enzymes (EFSA CEF Panel, 2016). The
assessment of the food processes covered in this opinion involved selection of relevant food groups
and application of process and technical conversion factors (Appendix B). These input data were
subject to a stakeholder consultation through open calls,7 and adjusted in accordance with feedback
received.
3.2.1. EFSA Comprehensive European Food Consumption Database
Since 2010, the EFSA Comprehensive European Food Consumption Database (hereinafter the EFSA
Comprehensive Database8) has been populated with detailed national data on food consumption.
Competent authorities in European countries provide EFSA with data regarding the level of food
consumption by individual consumers, as taken from the most recent national dietary survey in their
country (EFSA, 2011a).
The food consumption data gathered by EFSA were collected using different methodologies and
thus direct country-to-country comparisons should be made with caution. Depending on the food
category and the level of detail used in exposure calculations, uncertainties might be introduced owing
to subjects possibly underreporting and/or misreporting of consumption amounts. Nevertheless, the
EFSA Comprehensive Database is the best available source of food consumption data across Europe.
Food consumption data from the following population groups: infants, toddlers, children,
adolescents, adults and the elderly were used for the exposure assessment. For the present
assessment, food consumption data were available from 33 different dietary surveys carried out in 19
European countries (Appendix A).
Consumption records were codified according to the FoodEx classification system (EFSA, 2011b).
3.2.2. Exposure assessment methodology
Chronic exposure was calculated based on individual consumption, averaged over the total survey
period, excluding surveys with only one day per subject. High-level exposure/intake was calculated for
6 Annex III Part 3 of the Reg. (EU) No 1130/2011 amending Annex III to Regulation (EC) No 1333/2008 of the European
Parliament and of the Council on food additives by establishing a Union list of food additives approved for use in food
additives, food enzymes, food flavourings and nutrients.
7 http://www.efsa.europa.eu/en/data/call/161110
8 http://www.efsa.europa.eu/en/food-consumption/comprehensive-database
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only those population groups, in which the sample size was sufficiently large to allow calculation of the
95th percentile (EFSA, 2011a).
The exposure per FoodEx category was subsequently added to derive an individual total exposure
per day. Finally, these exposure estimates were averaged over the number of survey days and
normalised for individual body weight (bw), resulting in an individual average exposure/day per kg bw
for the survey period. This was done for all individuals in the survey and per age class, resulting in
distributions of individual average exposure per survey and age class. Based on these distributions, the
mean and 95th percentile exposures were calculated per survey for the total population and per age
class.
3.2.3. Exposure to food enzyme–TOS according to the intended use proposed by
the applicant
Dietary exposure to the food enzyme–TOS was based on intended use and the recommended
maximum use levels of the food enzyme–TOS provided by the applicant (Table 2). Food enzyme–TOS
exposure was calculated from foods produced involving a baking process.
Relevant food groups and/or individual foods were selected from the Comprehensive Database and
were assumed to always contain the food enzyme–TOS at the maximum recommended use level. This
will result in an overestimation of exposure to food enzyme–TOS.
To facilitate matching of the reported use levels for baking processes with foods identified in the
Comprehensive Database, the selected foods were disaggregated to ingredient level as appropriate,
and converted into the corresponding raw material, i.e. flour, via the application of conversion factors
(Appendix B). For example, consumption of 100 g of bread was converted into an intake of 70 g flour
(recipe fraction of 0.7) and then multiplied by 1.17 mg TOS/kg flour, as provided by the applicant, to
arrive at an exposure of 0.08 mg TOS/100 g bread.
Dietary exposure to the food enzyme–TOS was calculated by multiplying values reported for each
food category by their respective consumption amount per kilogram of body weight separately for
each individual in the database. Table 2 provides an overview of the derived exposure estimates. The
average and 95th percentile exposure to the food enzyme–TOS per age class, country and survey are
reported in Appendix C – Table 1. The contribution of the food enzyme–TOS from each FoodEx
category to the total dietary exposure is indicated in Appendix C – Table 2.
3.2.4. Uncertainty analysis
In accordance with the guidance provided in the EFSA opinion related to uncertainties in dietary
exposure assessment (EFSA, 2006), the following sources of uncertainties have been considered and
are summarised in Table 3.
Table 2: Summary of estimated dietary exposure to food enzyme–TOS in six population groups
Population
group
Estimated exposure (mg/kg bw per day)
Infants Toddlers Children Adolescents Adults The elderly

































Safety of glucose oxidase from A. oryzae (NZYM-KP)
www.efsa.europa.eu/efsajournal 10 EFSA Journal 2018;16(7):5319
The conservative approach applied to the exposure estimate to food enzyme–TOS, in particular,
assumptions made on the occurrence and use levels of this specific food enzyme, is likely to have led
to a considerable overestimation of the exposure.
3.3. Toxicological data
A battery of toxicological tests including a bacterial gene mutation assay (Ames test), an in vitro
mammalian chromosomal aberration test and a repeated dose 90-day oral toxicity study in rats has
been provided. The batch 4 (Table 1) which is used for toxicological testing has lower specific activity
compared to the batches used for commercialisation, and thus is considered cruder and suitable for
toxicological testing.
The principal enzyme activity of the tested material is glucose oxidase, producing hydrogen
peroxide (cytotoxic and mutagenic compound in vitro) in the presence of glucose. Therefore, in the
genotoxicity tests, the glucose oxidase was inactivated by heat treatment for 30 min at 60°C at pH 2
and subsequently adjusted to neutral pH. Considering the fact that the food enzyme is intended to be
used in baking processes, the Panel decided that this inactivation is representative for the food enzyme
as consumed.
3.3.1. Genotoxicity
3.3.1.1. Bacterial reverse mutation test
In order to investigate the potential of the food enzyme to induce gene mutations, a bacterial
reverse mutation assay (Ames test) was performed according to OECD Test Guideline 471 (OECD,
1997a) and following Good Laboratory Practice (GLP) in four strains of Salmonella Typhimurium
(TA1535, TA100, TA1537 and TA98) and E. coli WP2uvrA. The test was performed in the presence or
absence of metabolic activation applying the ‘treat and plate assay’ for Salmonella Typhimurium and
the direct plate incorporation assay for E. coli. Two experiments were carried out in triplicate plating
using six concentrations of the food enzyme (156, 313, 625, 1,250, 2,500 and 5,000 lg dry matter/
plate, corresponding to 127, 256, 511, 1,021, 2,042 and 4,084 lg TOS/plate), using appropriate
positive controls and sterile water as a negative control. All positive control chemicals induced
significant increases in revertant colony numbers, confirming the sensitivity of the tests and the
efficacy of the S9-mix. No toxicity was observed at any dose level of the test substance. However,
growth stimulation was observed in most of the tested conditions after treatment with the food
enzyme. This increase did not result in a noticeable increase in the corresponding levels of revertants.






Consumption data: different methodologies/representativeness/underreporting/
misreporting/no portion size standard
+/
Use of data from food consumption survey of a few days to estimate long-term
(chronic) exposure for high percentiles (95th percentile)
+
Possible national differences in categorisation and classification of food +/
Model assumptions and factors
FoodEx categories included in the exposure assessment were assumed to always
contain the food enzyme–TOS
+
Exposure to food enzyme–TOS was always calculated based on the recommended
maximum use level
+
Selection of broad FoodEx categories for the exposure assessment +
Use of recipe fractions in disaggregation FoodEx categories likely to contain the food
enzyme
+/
Use of technical factors in the exposure model +/
+: uncertainty with potential to cause overestimation of exposure; : uncertainty with potential to cause underestimation of
exposure.
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Upon treatment with the food enzyme, the numbers of the revertant colonies were comparable to the
values observed in the vehicle control groups in any tester strain, both in the presence and absence of
metabolic activation. The Panel concluded that the food enzyme did not induce gene mutations in the
bacterial reverse mutation assay under the test conditions employed for this study.
3.3.1.2. In vitro mammalian chromosome aberration test
The in vitro chromosome aberration test was carried out according to the OECD Test Guideline 473
(OECD, 1997b) and following GLP. Whole blood cultures were treated with purified water (negative
control), the food enzyme or appropriate positive controls both in the presence and absence of
metabolic activation. Based on the results of a preliminary cytotoxicity assay performed in a range of
concentrations from 38 to 5,000 lg food enzyme/mL, the cells were treated with 3,441, 4,301 and
5,376 lg food enzyme/mL (corresponding to 368, 460 and 575 lg TOS/mL) applying a short-term
treatment (3 h followed by 17 h recovery) in the presence and absence of S9-mix. The highest
concentration induced approximately 32% and 0% reduction in mitotic index in the absence and
presence of S9, respectively. In the second experiment, the concentrations of the food enzyme tested
were 501, 1,187 and 2,109 lg food enzyme/mL (corresponding to 54, 127 and 226 lg TOS/mL) in a
continuous treatment (20+0 h) without S9, and 3,613, 4,250 and 5,000 lg food enzyme/mL
(corresponding to 387, 455 and 535 lg TOS/mL) for the short treatment in the presence of S9-mix.
The highest concentrations induced approximately 49% and 0% reduction in mitotic index in the
absence and presence of S9, respectively. Two hundred metaphases per experimental point were
analysed. The Panel noted inconsistencies in the data reporting between the summary tables and the
detailed presentation of type and number of chromosomal aberrations observed. Overall, no
statistically significant increase in the frequency of chromosomal aberrations was observed in the
treated cultures compared to the negative controls. One exception was the intermediate concentration
tested (4,301 lg food enzyme/mL) in the short-term treatment in the presence of S9-mix, showing a
frequency of aberrations above the historical vehicle control range; this increase was not dose-related,
not statistically significant and not reproducible, and thus, it was considered not biologically relevant.
In addition, the Panel noted a value above the observed range of the vehicle controls also at the mid-
dose tested in the short-term treatment without S9-mix (4,301 lg food enzyme/mL). The increase was
not dose-related or statistically significant, therefore was not considered of biological relevance. The
frequencies of cells with numerical aberrations fell within the historical negative control ranges in all
tested conditions. The Panel concluded that the food enzyme did not induce chromosomal aberration
in cultured human peripheral blood lymphocytes when tested under the experimental conditions
employed for this study.
3.3.2. Repeated dose 90-day oral toxicity study in rodents
A repeated dose 90-day oral toxicity study was performed according to OECD Test Guideline 408
(OECD, 1998) and following good laboratory practice (GLP). Four groups of 10 male and 10 female
specific-pathogen-free Sprague–Dawley (Crl:CD(SD)IGS BR) rats were given the food enzyme by
gavage at dose levels of 114, 341 or 1,135 mg TOS/kg bw per day. Controls received the vehicle
(water).
There was one unscheduled death in the high-dose male group during week 9 of the study,
probably due to misdosing.
In high-dose females, non-significant decreases in food consumption, body weight and body weight
gain were observed. These changes were only slight (below 10% compared to controls) and are not
considered to be adverse.
In the FOB tests for neurotoxicity (performed from week 1 to week 13), occasional deviations from
the control were observed. These sporadic changes did not show a dose-response relationship and
were only seen at single time-points and therefore they were not considered to be adverse.
In haematology, a statistically significant increase in prothrombin time was observed in the high-dose
males. This was due to the high value in one animal and therefore not considered to be of toxicological
concern. In the low- and mid-dose males, statistically significant increases in neutrophils associated with
a non-significant increase in white blood cell counts were observed. No differences were observed in
females. A statistically significant increase in mean absolute spleen weight was observed in the low- and
mid-dose males without any pathological changes. As this increase was slight, and no dose-related, this
effect was not considered relevant.
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In clinical chemistry, the values for which significant differences were observed were sporadic, not
dose-related and were small in magnitude. The effects were considered to be of no toxicological
relevance.
At necropsy and histopathology, evaluation of dark (3/10) and spongy lung lobes (2/10) and/or
subacute interstitial pneumonia in high-dose males (2/10) was observed. One of these animals also
had oesophageal myositis. The 90-day study authors ascribe these lung effects to the gavage-dosing
procedure, but it is noteworthy that both occurred only in the high dose and not at any other dose
level or in the females. In addition, the intercurrent death (i.e. animal 37) had the same type of lung
damage. In the absence of better evidence that these lung effects are indeed the result of gavage
misdosing, these observations should be taken into account.
No other significant effects were observed.
Overall, the Panel derived a no-observed-adverse-effect level (NOAEL) based on the mid-dose level
of 341 mg TOS/kg bw per day.
The NOAEL derived from 341 mg TOS/kg bw per day was compared to the exposure estimates of
0.010–0.088 mg/kg bw per day at the mean and from 0.030 to 0.156 mg TOS/kg bw per day at the
95th percentile, resulted in a margin of exposure (MOE) above 2,186, indicating that there is no safety
concern.
3.4. Allergenicity
The allergenicity assessment considers only the food enzyme and not any carrier or other excipient
which may be used in the final formulation.
The potential allergenicity of glucose oxidase produced with the genetically modified A. oryzae
strain NZYM-KP was assessed by comparison of its amino acid sequence with those of known allergens
according to the ‘EFSA Scientific opinion on the assessment of allergenicity of GM plants and
microorganisms and derived food and feed of the Scientific Panel on Genetically Modified Organisms’
(EFSA GMO Panel, 2010). Using higher than 35% identity in a window of 80 amino acids as the
criterion, one match was found. The matching allergen was Mala s 12 from Malassezia sympodialis
(formerly known as Pityrosporum), which is a ubiquitous component of the human skin microbiome.
Mala s 12 has sequence similarity with the glucose-methanol-choline oxidoreductase enzyme
superfamily (Zargari et al., 2007), which also includes glucose oxidase. Mala s 12 is a known contact
allergen that can induce IgE- and T-cell-mediated allergic reaction in atopic eczema patients
characterised by an impaired skin barrier. Considering that oral allergic reactions are mediated by IgE,
elicitation reactions upon dietary exposure to this food enzyme cannot be excluded but as the yeast
that expresses this allergen is an ubiquitous component of the skin microflora, the likelihood of such
elicitation reactions to occur after oral exposure through food is considered to be low.
No oral or respiratory allergic reactions to this glucose oxidase have been reported.
The applicant provided a study by Bindlev-Jensen et al. (2006) who investigated the possible cross
reactivity of 19 different commercial food enzymes in allergic patients (400 patients allergic to
inhalation allergens, food allergens, allergens of bee or wasp). Glucose oxidase from a genetically
modified A. oryzae donor organism was positive in the skin prick test in three patients. The enzyme
was further tested by ingestion (double-blind, placebo-controlled food challenge (DBPCFC)) and found
to be negative to both active and placebo challenges. Despite the fact that no allergic reactions have
been observed in these individuals, no conclusion can be drawn since the amino acid sequences of the
allergens to which the patients were sensitised are not known.
The Panel considers that under the intended condition of use the risk of allergic sensitisation and
elicitation reactions upon dietary exposure to this food enzyme cannot be excluded but the likelihood
of such reactions occurring is considered to be low.
Conclusions
Based on the microbial source, the genetic modifications, the manufacturing process, the
compositional, biochemical, toxicological data and the dietary exposure assessment, the Panel concluded
that the food enzyme glucose oxidase produced with the genetically modified A. oryzae strain NZYM-KP
does not give raise to safety concerns under the intended conditions of use.
Regarding the allergenicity assessment, the risk of allergic sensitisation and elicitation reactions
upon dietary exposure to this food enzyme cannot be excluded, but the likelihood of such reactions to
occur can be considered to be low.
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Documentation provided to EFSA
1) Dossier ‘Glucose oxidase from a genetically modified strain of Aspergillus oryzae (strain
NZYM-KP)’. August 2013. Submitted by Novozymes A/S.
2) Additional information submitted on 3 September 2014 by the applicant.
3) Additional information submitted in October 2017 by the applicant.
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CAS Chemical Abstracts Service
CFU colony forming units
DBPCFC double-blind, placebo-controlled food challenge
EINECS European Inventory of Existing Commercial Chemical Substances
GLP good laboratory practice
GMM genetically modified microorganism
GMP Good Manufacturing Practice
GODU Glucose Oxidase Units
HACCP Hazard Analysis and Critical Control Points
IgE immunoglobulin E
IUBMB International Union of Biochemistry and Molecular Biology
MOE margin of exposure
NOAEL no-observed-adverse-effect level
OECD Organisation for Economic Cooperation and Development
PCR polymerase chain reaction
QPS qualified presumption of safety
SDS-PAGE sodium dodecyl sulfate-poly acrylamide gel electrophoresis
TOS total organic solids
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Appendix A – Population groups considered for the exposure assessment
Population Age range
Countries with food consumption surveys covering more
than one day
Infants From 12 weeks up to and
including 11 months of age
Bulgaria, Denmark, Finland, Germany, Italy, United Kingdom
Toddlers From 12 months up to and
including 35 months of age
Belgium, Bulgaria, Denmark, Finland, Germany, Italy, Netherlands,
Spain, United Kingdom
Children(a) From 36 months up to and
including 9 years of age
Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland,
France, Germany, Greece, Italy, Latvia, Netherlands, Spain,
Sweden, United Kingdom
Adolescents From 10 years up to and
including 17 years of age
Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland,
France, Germany, Italy, Latvia, Spain, Sweden, United Kingdom
Adults From 18 years up to and
including 64 years of age
Austria, Belgium, Czech Republic, Denmark, Finland, France,
Germany, Hungary, Ireland, Italy, Latvia, Netherlands, Romania,
Spain, Sweden, United Kingdom
The elderly(a) From 65 years of age and
older
Austria, Belgium, Denmark, Finland, France, Germany, Hungary,
Ireland, Italy, Romania, Sweden, United Kingdom
(a): The terms ‘children’ and ‘the elderly’ correspond, respectively, to ‘other children’ and the merge of ‘elderly’ and ‘very elderly’
in the Guidance of EFSA on the ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure
Assessment’ (EFSA, 2011a).
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Appendix B – FoodEx categories used to derive exposure estimates for the
food enzyme–TOS and the respective conversion factors










A.01 Grains and grain-based products (unspecified) 0.8 1 13.9
A.01.03 Grain milling products (unspecified) 1 1 13.9
A.01.03.001 Wheat milling products (unspecified) 1 1 13.9
A.01.03.001.001 Wheat flour, brown 1 1 13.9
A.01.03.001.002 Wheat flour, Durum 1 1 13.9
A.01.03.001.003 Wheat flour, white 1 1 13.9
A.01.03.001.004 Wheat flour, wholemeal 1 1 13.9
A.01.03.001.005 Graham flour 1 1 13.9
A.01.03.001.006 Wheat flour, gluten free 1 1 13.9
A.01.03.001.014 Wheat starch 1.2 1 13.9
A.01.03.002 Rye milling products (unspecified) 1 1 13.9
A.01.03.002.001 Rye flour, gluten free 1 1 13.9
A.01.03.002.002 Rye flour, light 1 1 13.9
A.01.03.002.003 Rye flour, medium 1 1 13.9
A.01.03.002.004 Rye flour, wholemeal 1 1 13.9
A.01.03.003 Buckwheat milling products (unspecified) 1 1 13.9
A.01.03.003.001 Buckwheat flour 1 1 13.9
A.01.03.004 Corn milling products (unspecified) 1 1 13.9
A.01.03.004.001 Corn flour 1 1 13.9
A.01.03.004.003 Corn starch 1.3 1 13.9
A.01.03.005 Oat milling products (unspecified) 1 1 13.9
A.01.03.005.002 Oat flour 1 1 13.9
A.01.03.005.004 Oat starch 1.2 1 13.9
A.01.03.006 Rice milling products (unspecified) 1 1 13.9
A.01.03.006.001 Rice flour 1 1 13.9
A.01.03.006.002 Rice flour, white 1 1 13.9
A.01.03.006.003 Rice flour, instant 1 1 13.9
A.01.03.006.004 Rice starch 1.2 1 13.9
A.01.03.007 Spelt milling products 1 1 13.9
A.01.03.008 Other milling products (unspecified) 1 1 13.9
A.01.03.008.001 Amaranth flour 1 1 13.9
A.01.03.008.002 Barley flour 1 1 13.9
A.01.03.008.003 Chapatti flour 1 1 13.9
A.01.03.008.004 Flour mix, wheat/rye/barley/oats 1 1 13.9
A.01.03.008.005 Millet flour 1 1 13.9
A.01.03.008.007 Sorghum flour 1 1 13.9
A.01.04 Bread and rolls (unspecified) 1 0.7 13.9
A.01.04.001 Wheat bread and rolls 1 0.7 13.9
A.01.04.002 Rye bread and rolls 1 0.7 13.9
A.01.04.003 Mixed wheat and rye bread and rolls 1 0.7 13.9
A.01.04.004 Multigrain bread and rolls 1 0.7 13.9
A.01.04.005 Unleavened bread, crisp bread and rusk
(unspecified)
1 0.8 13.9
A.01.04.005.001 Crisp bread, rye wholemeal 1 0.9 13.9
A.01.04.005.002 Crisp bread, rye, light 1 0.9 13.9
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A.01.04.005.003 Crisp bread, wheat, wholemeal 1 0.9 13.9
A.01.04.005.004 Crisp bread, wheat, light 1 0.9 13.9
A.01.04.005.005 Rusk, light 1 0.9 13.9
A.01.04.005.006 Rusk, wholemeal 1 0.9 13.9
A.01.04.005.007 Pita bread 1 0.7 13.9
A.01.04.005.008 Matzo 1 0.9 13.9
A.01.04.005.009 Tortilla 1 0.7 13.9
A.01.04.006 Other bread 1 0.7 13.9
A.01.04.007 Bread products 1 0.7 13.9
A.01.07 Fine bakery wares (unspecified) 1 0.5 13.9
A.01.07.001 Pastries and cakes (unspecified) 1 0.5 13.9
A.01.07.001.001 Beignets 1 0.15 13.9
A.01.07.001.002 Buns 1 0.7 13.9
A.01.07.001.003 Cake from batter 1 0.25 13.9
A.01.07.001.004 Cheese cream cake 1 0.24 13.9
A.01.07.001.005 Cheese cream sponge cake 1 0.24 13.9
A.01.07.001.006 Chocolate cake 1 0.24 13.9
A.01.07.001.007 Chocolate cake with fruits 1 0.24 13.9
A.01.07.001.008 Cream cake 1 0.24 13.9
A.01.07.001.009 Cream cheese cake 1 0.24 13.9
A.01.07.001.010 Cream custard cake 1 0.24 13.9
A.01.07.001.011 Cream custard sponge cake 1 0.24 13.9
A.01.07.001.012 Croissant 1 0.5 13.9
A.01.07.001.013 Croissant, filled with chocolate 1 0.5 13.9
A.01.07.001.014 Croissant, filled with cream 1 0.5 13.9
A.01.07.001.015 Croissant, filled with jam 1 0.5 13.9
A.01.07.001.016 Croquembouche 1 0.15 13.9
A.01.07.001.017 Doughnuts 1 0.24 13.9
A.01.07.001.018 Eclair 1 0.15 13.9
A.01.07.001.019 Flan 1 0.5 13.9
A.01.07.001.020 Fruit cake 1 0.6 13.9
A.01.07.001.021 Fruit pie 1 0.15 13.9
A.01.07.001.022 Cheese pie 1 0.15 13.9
A.01.07.001.023 Fruit tart 1 0.15 13.9
A.01.07.001.024 Gingerbread 1 0.6 13.9
A.01.07.001.025 Gougere 1 0.15 13.9
A.01.07.001.026 Kringles 1 0.25 13.9
A.01.07.001.027 Nut cream cake 1 0.24 13.9
A.01.07.001.028 Pancakes 1 0.25 13.9
A.01.07.001.029 Profiterole 1 0.15 13.9
A.01.07.001.030 Pyramid cake 1 0.25 13.9
A.01.07.001.031 Rhubarb flan 1 0.15 13.9
A.01.07.001.032 Scone 1 0.5 13.9
A.01.07.001.033 Sponge dough 1 0.25 13.9
A.01.07.001.034 Sponge cake 1 0.25 13.9
A.01.07.001.035 Sponge cake roll 1 0.25 13.9
A.01.07.001.036 Muffins 1 0.25 13.9
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A.01.07.001.037 Waffles 1 0.25 13.9
A.01.07.001.038 Apple strudel 1 0.15 13.9
A.01.07.001.039 Cream-cheese strudel 1 0.24 13.9
A.01.07.001.040 Cheese pastry goods from puff pastry 1 0.15 13.9
A.01.07.001.041 Croissant from puff pastry 1 0.6 13.9
A.01.07.001.042 Brioche 1 0.5 13.9
A.01.07.001.044 Lebkuchen 1 0.6 13.9
A.01.07.001.045 Dumpling 1 0.5 13.9
A.01.07.001.046 Cake marbled, with chocolate 1 0.5 13.9
A.01.07.001.047 Marzipan pie 1 0.25 13.9
A.01.07.001.048 Baklava 1 0.15 13.9
A.01.07.002 Biscuits (cookies) 1 0.9 13.9
A.01.07.002.001 Biscuits, sweet, plain 1 0.9 13.9
A.01.07.002.002 Biscuits, chocolate filling 1 0.81 13.9
A.01.07.002.003 Biscuits, cream filling 1 0.81 13.9
A.01.07.002.004 Biscuits, fruit filling 1 0.81 13.9
A.01.07.002.005 Biscuits, vanilla filling 1 0.81 13.9
A.01.07.002.006 Butter biscuits 1 0.81 13.9
A.01.07.002.007 Biscuit, iced 1 0.81 13.9
A.01.07.002.008 Speculaas 1 0.9 13.9
A.01.07.002.009 Biscuits, sweet, wheat wholemeal 1 0.9 13.9
A.01.07.002.010 Biscuits, oat meal 1 0.9 13.9
A.01.07.002.011 Biscuits, spelt meal 1 0.9 13.9
A.01.07.002.012 Biscuits, salty 1 0.9 13.9
A.01.07.002.013 Biscuits, salty, with cheese 1 0.81 13.9
A.01.07.002.014 Sticks, salty 1 0.81 13.9
A.17.03.003 Biscuits, rusks and cookies for children 1 0.9 13.9
A.18.04.001 Find bakery products for diabetics 1 0.5 13.9
A.19.01.001 Sandwich and sandwich-like meal 1 0.32 13.9
A.19.01.002 Pizza and pizza-like pies 1 0.3 13.9
TOS: total organic solids.
(a): Available online: http://www.fao.org/fileadmin/templates/ess/documents/methodology/tcf.pdf
(b): Derived from publically available recipe information, and/or food label information (such as Mintel’s Global New Products
Database http://www.mintel.com/global-new-products-database).
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Appendix C – Dietary exposure estimates to the food enzyme–TOS in
details
Information for this appendix is provided in an Excel file (downloadable https://efsa.onlinelibrary.
wiley.com/doi/10.2903/j.efsa.2018.5319#efs25319-sup-0001).
The file contains two sheets, corresponding to two tables.
Table 1: Average and 95th percentile exposure to the food enzyme–TOS per age class, country and
survey.
Table 2: The contribution of the food enzyme–TOS from each FoodEx category to the total dietary
exposure.
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